Individual Investor · Agent Unfolded

Ali Farahanchi

Managing Partner · Camford Capital

Menlo Park, California, United States

Ali Farahanchi, Ph.D., is Managing Partner at Camford Capital, where he leads early-stage investments across healthcare, biotechnology and AI. He is also identified as a co-founder and Head of Business and Operations at Lavita, a healthcare technology company. His work combines venture investing, company building and scientific research.

Professional profile Camford Capital profile ↗
Ali Farahanchi, Ph.D., Managing Partner at Camford Capital

Portrait: Ali Farahanchi’s professional website

Investor overview

Farahanchi is Managing Partner at Camford Capital, an early-stage investment firm with a focus that spans technology and life sciences. Camford’s current team page identifies him as Managing Partner. His professional biography says he has led early-stage investments for the firm since 2016, with an emphasis on healthcare, biotech and AI.

His background combines scientific training with venture investing and operating experience. Before moving into venture capital, he worked as a management consultant at Kearney across healthcare, finance and operations practices. His biography also identifies him as a co-founder and Head of Business and Operations at Lavita.

Farahanchi’s profile is notable for its intersection of AI and life sciences. His investment and advisory activity includes biotechnology companies, therapeutic platforms and AI infrastructure, including FedML. These are firm and career associations; they should not be interpreted as evidence that he personally led every financing round.

Investment focus

Artificial IntelligenceHealthcareBiotechnologyTherapeuticsDiagnosticsAI InfrastructureMachine Learning

His stated areas of investment include healthcare, biotech and AI. The portfolio and board associations show particular exposure to therapeutics, computational biology, diagnostics, antibody discovery and machine-learning infrastructure. Camford’s broader investment activity also spans technology categories beyond life sciences.

Selected investments and company associations

The companies below are drawn from Farahanchi’s public professional biography and other portfolio records. The relationships differ by company and may include investment, advisory or board roles. They are not all represented as personal lead investments.

Engine BiosciencesBiotechnology and computational biology
Totus MedicinesAI-enabled drug discovery and therapeutics
Alchemab TherapeuticsAntibody discovery and therapeutics
Carbon BiosciencesGene therapy and biotechnology
SyntiantDeep learning solutions and edge AI
Surge TherapeuticsLocalized immunotherapy
CG OncologyOncolytic immunotherapy
FedMLFederated and distributed AI platform

Professional background

Camford Capital: Managing Partner. His biography states that he has led early-stage investments in healthcare, biotech and AI for the firm since 2016.

Lavita: Co-founder and Head of Business and Operations, according to his professional biography.

Kearney: Previously worked in management consulting across healthcare, finance and operations practices.

Board and advisory work: His biography lists involvement with Engine Biosciences, Totus Medicines, Alchemab Therapeutics, Carbon Biosciences, Syntiant, Surge Therapeutics, CG Oncology and FedML.

Education

Massachusetts Institute of Technology: Ph.D. in Systems Engineering.

Johns Hopkins University: Master’s degree in Biotechnology.

University of Chicago Booth School of Business: MBA.

Frequently asked questions

Who is Ali Farahanchi?

Ali Farahanchi, Ph.D., is Managing Partner at Camford Capital and a co-founder and Head of Business and Operations at Lavita. He has led early-stage investments in healthcare, biotechnology and AI.

What is Ali Farahanchi’s role at Camford Capital?

Camford Capital lists Ali Farahanchi, Ph.D., as its Managing Partner. His biography says he has led early-stage investments for the firm since 2016.

What sectors does Ali Farahanchi invest in?

His stated investment experience includes healthcare, biotechnology and AI, with a portfolio spanning therapeutics, diagnostics, biotech platforms and machine-learning infrastructure.

Which AI companies has Ali Farahanchi backed?

Public profiles associate his investment activity with FedML and Syntiant, among other technology and healthcare companies. Camford’s portfolio includes companies across several sectors, not only AI.

What companies has Ali Farahanchi advised or served on the board of?

His biography lists Engine Biosciences, Totus Medicines, Alchemab Therapeutics, Carbon Biosciences, Syntiant, Surge Therapeutics, CG Oncology and FedML.

Where did Ali Farahanchi study?

He holds a Ph.D. in Systems Engineering from MIT, a master’s degree in Biotechnology from Johns Hopkins University, and an MBA from the University of Chicago Booth School of Business.

Corrections or updates? If you spot an error or have information that should be updated in this profile, please contact hello@agentunfolded.com.

← Explore the AI Investor Directory
Scroll to Top